Minimally Invasive Mitral Valve Surgery in Mitral Valve Endocarditis: A Single-Center Experience

Background: Minimally invasive mitral valve surgery (MIMVS) is the gold standard for mitral valve pathologies; however, it is technically more challenging especially in patients with endocarditis. Here, we compare the early postoperative outcome of patients with endocarditis and other indications for MIMVS.

Methods: Two groups were formed, one consisting of patients who underwent surgery because of mitral valve endocarditis (study group: n = 73) and the other group consisting of patients who had another indication for MIMVS (control group: n = 819). Patients were observed for 30 postoperative days and 30-day mortality was considered as primary endpoint.

Results: Data were retrospectively reviewed and collected from January 2011 until December 2022. Patients from the study group were younger (60 vs. 68 years; p < 0.001) and had a higher preoperative incidence of stroke (26% vs. 6%; p < 0.001) with neurological symptoms (26% vs. 9%; p < 0.001). The repair rate was lower in the study group (45% vs. 64%; p = 0.003) and mechanical valves were more often used in the study group in case of replacement (25% vs. 11%; p < 0.001). No difference was seen in overall surgery time (211 vs. 206 minutes; p = 0.71), time on cardiopulmonary bypass (137 vs. 137 minutes; p = 0.42) and aortic clamping time (76 vs. 78 minutes; p = 0.42). Concerning postoperative data, the study group had a higher requirement of erythrocyte transfusion (2 vs. 0; p = 0.041). But no difference was seen in the need for a mitral valve redo-procedure (4% vs. 1%; p = 0.09), bleeding (12% vs. 7%; p = 0.16), stroke (3% vs. 2%; p = 0.38), cerebral bleeding (1% vs. 0%; p = 0.31), new onset dialysis (5% vs. 3%; p = 0.32), overall intubation time (11 vs. 11 hours; p = 0.13), sepsis (1% vs. 2%; p = 1), pacemaker implantation (1% vs. 6%; p = 0.11), wound healing disorders (4% vs. 6%; p = 0.47) and 30-day mortality (4% vs. 2%; p = 0.42).

Conclusion: Minimally invasive mitral valve surgery in patients with mitral valve endocarditis was feasible with a low early postoperative mortality. Despite a higher preoperative prevalence of stroke and neurological symptoms, postoperative stroke and intracerebral bleeding incidences remained low.

 

Scroll to top

No conflict of interest has been declared by the author(s).

Publication History

Article published online:
13 February 2024